|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 217.99 USD | -7.10% |
|
-9.55% | +19.36% |
| 07-31 | Mizuho Trims Price Target on Axsome Therapeutics to $306 From $310, Keeps Outperform Rating | MT |
| 07-21 | BMO Capital Initiates Axsome Therapeutics at Outperform With $310 Price Target | MT |
Chart calendar Axsome Therapeutics, Inc.
Upcoming events on Axsome Therapeutics, Inc.
| 2026-08-10 | Earnings release - Q2 2026 | |
| 2026-08-10 | Earnings presentation | 08:00 |
Past events on Axsome Therapeutics, Inc.
| 2026-06-05 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-06-05 | Annual General Meeting | 09:00 |
| 2026-05-04 | Earnings presentation | 08:00 |
| 2026-05-04 | Earnings release - Q1 2026 | |
| 2026-05-01 | Information meeting | 08:00 |
| 2026-02-23 | Earnings release - Q4 2025 | |
| 2026-02-23 | Earnings presentation | 08:00 |
| 2025-11-03 | Earnings release - Q3 2025 | |
| 2025-11-03 | Earnings presentation | 08:00 |
| 2025-08-04 | Earnings release - Q2 2025 | |
| 2025-08-04 | Earnings presentation | 08:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 271 268 0.91% | 386 385 0.16% | 638 636 0.42% | 979 | 1 596 | 2 260 |
|
EBITDA Million USD | Released Forecast Spread | -225 -166 -35.15% | -274 -230 -19.2% | -160 -158 -1.15% | -137 | 236 | 532 |
|
EBIT Million USD | Released Forecast Spread | -232 -184 -26.09% | -281 -244 -14.98% | -167 -170 2.01% | -98,1 | 334 | 843 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -238 -194 -23.13% | -287 -259 -10.89% | -184 -186 1.02% | -104 | 326 | 828 |
|
Net income Million USD | Released Forecast Spread | -239 -194 -23.53% | -287 -262 -9.8% | -183 -184 0.3% | -107 | 309 | 763 |
|
EPS USD | Released Forecast Spread | -5,27 -4,25 -23.9% | -5,99 -5,47 -9.44% | -3,68 -3,78 2.75% | -2,06 | 5,55 | 13,4 |
| Announcement Date | 20/02/24 | 18/02/25 | 23/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 105 98,1 6.82% | 119 118 0.79% | 121 119 1.83% | 150 138 8.71% | 171 163 5.1% | 196 193 1.42% | 191 191 0.27% | 222 | 263 | 306 | 296 | 347 | 393 | 448 | 367 |
|
EBITDA Million USD | Released Forecast Spread | -70,9 -46,1 -53.75% | -55,3 -78,4 29.48% | -35,0 -60,2 41.85% | -44,4 -48,6 8.63% | -25,2 -43,7 42.19% | -61,6 -62,7 1.79% | -22,0 | 24,7 | 78,9 | 78,3 | 101 | 118 | 146 | 153 | |
|
EBIT Million USD | Released Forecast Spread | -62,6 -64,7 3.23% | -72,6 -46,0 -57.74% | -57,0 -62,4 8.64% | -36,7 -51,7 29.01% | -46,1 -41,0 -12.51% | -27,0 -30,6 11.77% | -63,4 -42,1 -50.54% | -38,2 | -9,09 | 25,6 | 26,1 | 50,8 | 75,2 | 106 | 153 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -64,6 -65,1 0.78% | -74,8 -49,8 -50.41% | -59,4 -67,5 11.94% | -48,9 -55,7 12.16% | -47,2 -43,4 -8.93% | -28,1 -34,4 18.26% | -64,5 -45,7 -41.08% | -40,4 | -10,6 | 24,9 | 24,4 | 49,0 | 73,5 | 105 | 154 |
|
Net income Million USD | Released Forecast Spread | -64,6 -66,9 3.41% | -74,9 -49,0 -52.99% | -59,4 -66,3 10.33% | -48,0 -55,1 12.98% | -47,2 -43,9 -7.61% | -28,6 -33,7 15.18% | -64,5 -44,5 -44.95% | -42,3 | -13,1 | 23,1 | 22,0 | 44,2 | 66,0 | 94,0 | 146 |
|
EPS USD | Released Forecast Spread | -1,34 -1,41 5% | -1,54 -1,02 -51.7% | -1,22 -1,35 9.76% | -0,97 -1,12 13.29% | -0,94 -0,88 -7.26% | -0,56 -0,69 18.91% | -1,26 -0,90 -40.46% | -0,89 | -0,33 | 0,29 | 0,02 | 0,50 | 0,99 | 1,48 | 2,42 |
| Announcement Date | 12/11/24 | 18/02/25 | 05/05/25 | 04/08/25 | 03/11/25 | 23/02/26 | 04/05/26 | - | - | - | - | - | - | - | - |
| 2026-08-03 |  | Earnings release - Q2 2026 | |
| 2026-08-03 | | Earnings presentation | 08:30 |
| 2026-08-03 | | Earnings presentation | 08:00 |
| 2026-08-03 | | Earnings release - Q3 2026 | |
| 2026-08-03 | | Earnings presentation | 06:00 |
| 2026-08-03 | | Extraordinary General Meeting | 02:00 |
| 2026-08-05 | | Significant Split/Dividend | 00:00 |
| 2026-08-05 | | Earnings release - Q2 2026 | |
| 2026-08-05 | | Earnings presentation | 16:30 |
| 2026-08-05 | | Earnings presentation | 16:30 |
Past sector events for Axsome Therapeutics, Inc.
| 2026-07-31 | | Earnings presentation | 08:00 |
| 2026-07-31 | | Earnings release - Q2 2026 | |
| 2026-07-31 | | Annual General Meeting | 02:30 |
| 2026-07-31 | | Présentation aux Actionnaires / Analystes | 02:30 |
| 2026-07-31 | | Earnings release - Q1 2027 | |
| 2026-07-31 | | Extraordinary General Meeting | 02:30 |
| 2026-07-30 | | Earnings presentation | 08:30 |
| 2026-07-30 | | Earnings release - Q2 2026 | |
| 2026-07-30 | | Earnings presentation | 08:00 |
| 2026-07-30 | | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AXSM Stock
- Calendar Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
